#ICYMI: Thank you @UBCMedicine for highlighting how Alpha-9 is translating foundational UBC and BC Cancer research into targeted #radiopharmaceuticals that will help people living with #cancer thrive. Read more about our researchers-turned-team ➡️med.ubc.ca/news/ubc-biotech-…

Today, Alpha-9 announced a key appointment to the leadership team and the formation of its Scientific Advisory Board. This team will bring invaluable expertise to Alpha-9 as we advance novel #radiopharmaceuticals. Learn more: alpha9tx.com/alpha-9-therano…

Did you catch us on the big screen in Times Square? Thank you @Nasdaq for highlighting our Series B financing news. We couldn't have asked for a better way to close out this incredible year. Cheers, and here's to 2023! #Biotech #Oncology

Alpha-9 is engineering highly effective, bespoke #radiopharmaceuticals for the treatment of #SolidTumors and #hematologic malignancies. This Series B will support advancement of five programs into the clinic while expanding our early-stage pipeline. #biotech #cancer

Today Alpha-9 Theranostics announces the closing of a $75 million Series B financing to harness the power of #radiopharmaceuticals for effective #cancer treatments and advance five programs into the clinic. Learn more: alpha9tx.com/alpha-9-therano…